The shareholders in CellaVision AB (publ) are hereby summoned to the
annual general meeting, to be held on Wednesday April 23 2008 at
17.00 at CellaVision AB, Scheelevägen 19 A, Delta 5, Lund, Sweden.
The notice is available in Swedish only, please see the link below.
For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 46-286 44 00. E-mail: yvonne.martensson@cellavision.com
Johan Wennerholm, CFO, CellaVision AB
Phone: +46 46-286 44 00. E-mail: johan.wennerholm@cellavision.com
About CellaVision
CellaVision AB develops, markets, and sells the market leading image
analysis based systems for routine analysis of blood and other body
fluids. The company has a core competence in development of software
for automatic image analysis of cells and cell changes for
applications in health and medical care. The company develops and
markets systems for automatic differentials of white blood cells and
red morphology, and software for education and quality assurance of
differentials. The company's associates have expertise in advanced
imaging analysis, artificial intelligence, and automated microscopy.
The company headquarters are in Lund, Sweden and has subsidiaries in
Jupiter, FL, USA, and Toronto, ON, Canada. For more information,
visit www.cellavision.com.
CellaVision's share is listed on First North at the OMX Stockholm
Stock Exchange. The company's Certified Advisor is Remium AB.
